FDA lifts partial clinical hold on Rezolute hypoglycemia treatment
Resolute said the U.S. Food and Drug Administration has lifted the partial clinical hold on its late-stage study testing its treatment for low blood sugar, sending its shares up 11% to $4.83.
BELIEBTE BEITRÄGE
Bluetongue outbreak in a Portuguese sheep farm has broken out
September 19, 2024
Austria says disaster fund to rise to 1 billion euros
September 19, 2024
Portugal gets help from Spain and Morocco in response to fires
September 19, 2024
Drought reduces Amazon rivers to historic lows
September 19, 2024
LIVEÜBERTRAGUNG